Dimiracetam - ISF

Drug Profile

Dimiracetam - ISF

Alternative Names: ISF 4185

Latest Information Update: 11 Jan 2005

Price : $50

At a glance

  • Originator ISF
  • Class Non-opioid analgesics; Nootropics; Pyrrolidinones; Small molecules
  • Mechanism of Action Cholinergic receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Alzheimer's disease

Most Recent Events

  • 21 Jan 2000 Discontinued - Preclinical for Alzheimer's disease in Italy (PO)
  • 21 Jan 1997 No-Development-Reported for Alzheimer's disease in Italy (PO)
  • 13 Oct 1994 Preclinical development for Alzheimer's disease in Italy (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top